Silgan Holdings (SLGN) reported first quarter results at the high end of expectations, with revenue of US$1,561.3 million and earnings per share modestly below last year, while management raised full year earnings guidance after operational outperformance.
See our latest analysis for Silgan Holdings.
Silgan’s share price has been choppy, with a 4.5% 1 month share price return and a 6% 3 month share price decline, while the 1 year total shareholder return is 21.7%.
If this earnings reaction has you looking beyond packaging, it could be a good moment to scan other areas of the market through our 18 top founder-led companies
Silgan now trades below some analyst value estimates and shows an intrinsic value gap, yet recent returns have been weak. Is this a chance to pick up the stock at a discount, or is the market already baking in future growth?
Silgan’s most followed narrative pegs fair value at about $53.92 a share, compared with the last close of $40.55. It builds that gap using a detailed earnings and margin roadmap discounted at 8.37%.
Strong organic growth in high-value dispensing products and successful integration of the Weener acquisition create incremental cross-selling and innovation opportunities, especially in fast-growing end-markets like personal care, beauty, and home care, which is poised to support sustained above-market revenue growth and higher margins.
Want to see what turns that story into a higher fair value number? The narrative leans on measured revenue growth, rising margins, and a different future earnings multiple. The exact mix of those inputs may surprise you.
Result: Fair Value of $53.92 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, shifts toward fresh foods at the expense of shelf stable cans, along with pressure from customer concentration such as client bankruptcies, could quickly challenge that upside story.
Find out about the key risks to this Silgan Holdings narrative.
The mix of optimism and concern in this story is clear, so it makes sense to review the full picture now and decide where you stand with the 5 key rewards and 1 important warning sign.
If Silgan has sharpened your focus, do not stop here. Use the Simply Wall St Screener to uncover other opportunities that might fit your style and goals.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com